Health Exec

Health Exec Health Exec is an information resource providing strategic planning intelligence for C-suite hospital executives.

HealthExec.com is an information resource providing strategic planning intelligence for C-suite hospital executives.

DOJ accuses New Jersey doctor of illegally prescribing opiates in exchange for s*x.
07/21/2025

DOJ accuses New Jersey doctor of illegally prescribing opiates in exchange for s*x.

Ritesh Kalra, MD, allegedly wrote 31,000 opioid prescriptions between 2019 and 2025, many of which were illegitimate. He is accused of inappropriately touching patients in exchange for oxycodone scripts as part of a five-count criminal indictment.

Assembly issue spurs FDA recall on manual resuscitators.
07/21/2025

Assembly issue spurs FDA recall on manual resuscitators.

A problem with the B/V filters on SunMed adult resuscitators can cause the devices to malfunction. Due to the high safety risk this poses to patients, the FDA has assigned this recall its most serious designation.

Two insurers dominate most Medicare Advantage markets, report finds.
07/21/2025

Two insurers dominate most Medicare Advantage markets, report finds.

Over 97% of all counties in the U.S. see high or very high levels of consolidation in Medicare Advantage markets, with UnitedHealthcare and Humana owning the most plans nationwide.

Steward Health Care sues former CEO over alleged pilfering that contributed to bankruptcy.
07/18/2025

Steward Health Care sues former CEO over alleged pilfering that contributed to bankruptcy.

Former Steward Health Care CEO Ralph de la Torre, MD, and other executives are accused in a $1.4 billion legal filing of paying themselves hundreds of millions of dollars in bonuses, despite the health system being insolvent.

FDA recalls real-time glucose monitors after 56 injuries.
07/18/2025

FDA recalls real-time glucose monitors after 56 injuries.

Receivers on active glucose monitors manufactured by Dexcom are reportedly failing to send alerts when a patient’s blood sugar levels are dangerously high or low. There have been no deaths linked to the malfunction.

FDA issues recall on defective cranial drills after 10 injuries.
07/17/2025

FDA issues recall on defective cranial drills after 10 injuries.

The devices are manufactured by Integra LifeSciences. Due to a manufacturing error where inadequate welding has caused bits to get stuck in patients’ skulls, this recall has been designated as the most serious type.

07/17/2025

GOP senator introduces bill to repeal federal Medicaid cuts present in the ‘Big, Beautiful Bill.’

70% of healthcare cyberattacks result in delayed patient care, report finds.
07/16/2025

70% of healthcare cyberattacks result in delayed patient care, report finds.

According to a report from cybersecurity vendor Fortified Health Security, 92% of healthcare organizations reported a data breach last year, signaling that the space remains a prime target for data thieves. The analysis points to a need for improved staff training to bolster defenses.

HHS formally lays off thousands of employees following SCOTUS ruling.
07/16/2025

HHS formally lays off thousands of employees following SCOTUS ruling.

After the Supreme Court lifted a lower court injunction, approximately 10,000 employees at the U.S. Department of Health and Human Services were officially terminated.

07/15/2025

Judge overturns Biden-era rule that curbed medical debt reporting after the Consumer Financial Protection Bureau backs off enforcement.

Doctor accused of forging vaccine cards, injecting children with saline, has all charges dropped.
07/15/2025

Doctor accused of forging vaccine cards, injecting children with saline, has all charges dropped.

Under the direction of U.S. Attorney General Pam Bondi, charges against Michael Kirk Moore Jr., MD, were dropped just as his trial began. He had been accused of destroying 1,937 doses of COVID-19 vaccines and accepting kickbacks for falsifying vaccine records.

Walgreens’ $10B acquisition by private equity firm approved by shareholders.
07/14/2025

Walgreens’ $10B acquisition by private equity firm approved by shareholders.

Shareholders of the retail pharmacy giant voted in favor of the terms of the sale to Sycamore Partners for $11.45 a share. The deal is expected to close later this year.

Address

North Providence, RI

Alerts

Be the first to know and let us send you an email when Health Exec posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Health Exec:

Share